When the parties who originally submitted the peptides for FDA review withdraw their submissions, the peptides are removed from the category list, without landing anywhere definitive
in 2026 that nomination was withdrawn and BPC-157 was removed from Category 2, but the FDA has proposed against adding it to the 503A bulks list, so it remains unauthorized for compounding rather than cleared for it
10.1007/s13273-019-0034-8 172 LeeH.-S.KimY
CJC-1295 + Ipamorelin (Growth Hormone Secretagogues) Primary Use: Muscle growth, fat loss, anti-aging Stimulates natural growth hormone production without suppressing baseline levels Combine with our protein intake calculator to optimize muscle-building nutrition supporting muscle growth peptides effectiveness Best For: Body recomposition, age-related muscle loss 4
As of 2026, retatrutide has not received marketing authorisation from the MHRA or EMA and is only accessible within authorised clinical trials